Reduced toxicological activity of cigarette smoke by the addition of ammonium magnesium phosphate to the paper of an electrically heated cigarette: Smoke chemistry and in vitro cytotoxicity and genotoxicity

Toxicology in Vitro

Volumn 22, Issue 3, 2008, Pages 671-681

  Roemer, E ^a   Stabbert, R ^a   Veltel, D ^b   Muller B P ^c   Meisgen, T J ^b   Schramke, H ^a   Anskeit, E ^b   Elves, R G ^d   Fournier, J A ^d  

^a Philip Morris Products SA   (Switzerland)

^b Philip Morris Research Laboratories GmbH   (Germany)

^c Center for Research and Technology ^*  (United Kingdom)

^d Philip Morris USA   (United States)

Author keywords

Ammonium magnesium phosphate; Cigarette smoke; Cytotoxicity; Genotoxicity

Indexed keywords

AMMONIA; AMMONIUM MAGNESIUM PHOSPHATE; CIGARETTE SMOKE; NITROGEN; OXYGEN;

ANIMAL CELL; ARTICLE; BACTERIUM; CELL ASSAY; CHEMICAL COMPOSITION; CHEMISTRY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENOTOXICITY; HEATING; IN VITRO STUDY; LYMPHOMA CELL; MOUSE; MUTAGENICITY; NONHUMAN; PAPER; QUANTITATIVE ANALYSIS; TOXICITY TESTING;

ANIMALS; BALB 3T3 CELLS; CELL LINE; CELL SURVIVAL; GASES; MAGNESIUM COMPOUNDS; MICE; MUTAGENICITY TESTS; MUTAGENS; PAPER; PHOSPHATES; RATS; SALMONELLA TYPHIMURIUM; SMOKE; TOBACCO;

MURINAE; SALMONELLA;

EID: 40249105793     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.12.008     Document Type: Article

References (49)

1. Andrioli C., Gigante D., and Nunziata. A review of in vitro methods to assess the biological activity of tobacco smoke with the aim of reducing the toxicity of smoke. Toxicology in Vitro 17 (2003) 587-594
2. Baker R.R., Massey E.D., and Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food and Chemical Toxicology 42S (2004) S53-S83
3. Babich H., and Borenfreund E. Cytotoxic and morphological effects of phenylpropanolamine, caffeine, nicotine, and some of their metabolites studied in vitro. Toxicology in Vitro 6 (1992) 493-502
4. Banyasz J.L., Li S., Lyons-Hart J.L., and Shafer K.H. Cellulose pyrolysis: the kinetics of hydroxyacetaldehyde evolution. Journal of Analytical and Applied Pyrolysis 57 (2001) 223-248
5. Blaauboer B.J., Balls M., Barratt M., Casati S., Coecke S., Mohamed M.K., Moore J., Rall D., Smith K.R., Tennant R., Schwetz B.A., Stokes W.S., and Younes M. 13th Meeting of the scientific group on methodologies for the safety evaluation (SGOMSEC): Alternative testing methodologies and conceptual issues. Environmental Health Perspective 106 (1998) 413-418
6. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and Neutral Red absorption. Toxicology Letters 24 (1985) 119-124
7. CDC, Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 1994. Morbidity and Mortality Weekly Report 45 (1996) 588-590
8. Chepiga T.A., Morton M.J., Murphy P.A., Avalos J.T., Bombick B.R., Doolittle D.J., Bogerding M.F., and Swauger J.E. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food and Chemical Toxicology 38 (2000) 949-962
9. Clive D., Flamm W.G., and Mechesko M.R. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutation Research 16 (1972) 77-87
10. Cole J., Muriel W.J., and Bridges B.A. The mutagenicity of sodium floride to L5178Y [wild-type and Tk+/-(3.7.2c)] mouse lymphoma cells. Mutagenesis 1 (1986) 157-167
11. Counts M.E., Morton M.J., Laffoon S.W., Cox R.H., and Lipowicz P.J. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regulatory Toxicology and Pharmacology 41 (2005) 185-227
12. Diana J.N., and Vaught A. Research Cigarettes (1990), The University of Kentucky Printing Services, Lexington, KY
13. DeJongh J., Forsby A., Houston J.B., Beckman M., Combes R., and Blaauboer B.J. An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test methods: a prevalidation study based on the ECITTS project. Toxicology In Vitro 13 (1999) 549-554
14. Dreyfors J.M., Jones S.B., and Sayed Y. Hexamethylenetetramine: a review. Journal of the American Industrial Hygiene Association 50 (1991) 579-585
15. Dybing E., Soderlund E., Lag M., Brunborg G., Omichinski J.G., Dahl J.E., Holme J.A., and Nelson S.D. Cytotoxicity via interactions with DNA. In: Volans G.N., Sims J., Sullivan F.M., and Turner P. (Eds). Basic Science in Toxicology (1990), Taylor & Francis, London 651-659
16. Eclipse Expert Panel. A safer cigarette? A comparative study. A consensus report. Inhalation Toxicology 12 Suppl. 5 (2000) 1-48
17. Eisenbrand G., Pool-Zobel B., Baker V., Balls M., Blaauboer B.J., Boobis A., Career A., Kevekordes S., Lhuguenot J.-C., Pieters R., and Kleiner J. Methods of in vitro toxicology. Food and Toxicology 40 (2002) 193-236
18. Fournier, J.A., Paine III, J.B., 2001. Smoking article wrapper with improved filter. United States patent number 6,289,898. Issue date: September 18, 2001.
19. Gonzales J., and Sarabia J. An interesting compound of the sidestream smoke: haxamethylenetetramine. Proceedings of CORESTA Congress, Smoke Group Papers (1992), CORESTA, Jerez de la Frontera, Spain 127-141
20. INVITTOX. INVITTOX Protocol 3a. The FRAME Modified Neutral Red Uptake Cytotoxicity Test (1990), INVITTOX, Nottingham, England
21. IARC, International Agency for Research on Cancer, 1986. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Tobacco Smoking, vol. 38. Table 19 and Appendix 2. IARC, Lyon.
22. IARC, International Agency for Research on Cancer, 1999. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vols 1-73. IARC, Lyon, France.
23. IARC, International Agency for Research on Cancer, 2006. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol 88. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, IARC, Lyon, France.
24. ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996. Tripartite Guideline. Validation of Analytical Procedures: Methodology.
25. ISO, International Standards Organisation, 1991. Determination of total and nicotine-free dry particulate matter using routine analytical smoking machine. Standard 4387. ISO, Geneva, Switzerland.
26. ISO, International Standards Organisation, 1990. Tobacco and Tobacco Products - Atmospheres for Conditioning and Testing, fourth ed., Standard 3404. ISO, Geneva, Switzerland.
27. Maron D.M., and Ames B.N. Reviewed methods for the Salmonella mutagenicity test. Mutation Research 113 (1983) 173-215
28. MDPH, Massachusetts Department of Public health, Massachusetts General Laws Annotated, 1997. Chapter 94, Section 307B 105, Code of Massachusetts Regulations 660.000 et seq.
29. Mizobuchi M., Tamase K., Kitada Y., Sasaki M., and Tanigawa K. Liquid chromatographic determination of ammonium in water. Anal. Chem. 56 (1984) 603-605
30. OECD, Organization for Economic Cooperation and Development, 1997a. Guideline 471, Bacterial reverse mutation test. In: OECD Guidelines for Testing of Chemicals. OECD, Paris, France.
31. OECD, Organization for Economic Cooperation and Development, 1997b. Guideline 476, In vitro Cell Gene Mutation Test. In: OECD Guidelines for Testing of Chemicals. OECD, Paris, France.
32. Patskan G.J., and Reininghaus W. Toxicological evaluation of an electrically heated cigarette. Part 1: Overview of technical concepts and summary findings. Journal of Applied Toxicology 23 (2003) 323-328
33. Peeler, C.L., 1996. Cigarette testing and the federal trade commission: a historical overview. In: Report of the NCI expert committee. US Department of Health and Human Services, Public Health Service (Eds.) Smoking and Tobacco Control. Monograph 7. The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of US Cigarettes. National Institute of Health, Bethesda, MD.
34. Plunkett S., Parrish M.E., Shafer K.H., Nelson D., Shorter J., and Zahniser M. Time-resolved analysis of cigarette combustion gases using a dual infrared tunable diode laser system. Vibrational Spectroscopy 27 (2001) 52-63
35. Putnam K.P., Bombick D.W., James E.F., and Doolittle D.J. The cytotoxicity of smoke condensates from cigarettes in the US commercial compared to Kentucky reference cigarettes. Toxicological Sciences 60 Suppl. 1 (2001) 305
36. Restani P., Restelli A.R., and Galli C.L. Formaldehyde and hexamethylenetetramine as food additives: chemical interactions and toxicology. Food Additives and Contaminants 9 (1992) 597-605
37. Roemer E., Meisgen T.J., Tewes F.J., and Solana R.P. Discrimination of cigarette mainstream smoke condensates with the Salmonella Reverse Mutation Assay. The Toxicologist 42 1-S (1998) 295 Poster available at (Accessed 18.5.2007)
38. Roemer E., Tewes F.J., Meisgen T.J., Veltel D.J., and Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food and Chemical Toxicology 40 (2002) 105-111
39. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworsky C.L., and Podraza K.F. Chemical composition, cytotoxicity, and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195 (2004) 31-52
40. Roethig H.J., Kinser R., Nelson B., Oey B., and Wang N. Short term clinical exposure evaluation of conventional and electrically heated cigarettes. Journal of Clinical Pharmacology 42 (2002) 1065
41. Rustemeier K., Stabbert R., Haussmann H.-J., Roemer E., and Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food and Chemical Toxicology 40 (2002) 93-104
42. Schramke H., Meisgen T.J., Tewes F.J., Gomm W., and Roemer E. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 227 (2006) 193-210
43. Stabbert R., Voncken P., Rustemeier K., Haussmann H.-J., Roemer E., Schaffernicht H., and Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 2: Chemical composition of mainstream smoke. Journal of Applied Toxicology 23 (2003) 329-339
44. Steele R.H., Payne V.M., Fulp C.W., Rees D.C., Lee C.K., and Doolittle D.J. A comparison of the mutagenicity of mainstream cigarette smoke condensate from a representative sample of the US cigarette commercial with a Kentucky reference cigarette (K1R4F). Mutation Research 342 (1995) 179-190
45. Terpstra P.M., Teredesai A., Vanscheeuwijck P.M., Verbeek J., Schepers G., Radtke F., Kuhl P., Gomm W., Anskeit E., and Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 4: Subchronic inhalation toxicology. Journal of Applied Toxicology 23 (2003) 349-362
46. Tewes F.J., Veltel D.J., Heil M., and Solana R.P. Discrimination of cigarette mainstream smoke with the Neutral Red Uptake cytotoxicity assay. Toxicological Sciences 42 (1998) 295
47. Tewes F.J., Meisgen T.J., Veltel D.J., Roemer E., and Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 3: Genotoxicity and cytotoxicity of mainstream smoke. Journal of Applied Toxicology 23 (2003) 341-348
48. US CPSC, US Consumer Product Safety Commission in Consultation with the US Department of Health and Human Services, 1993. Toxicity Testing Plan for Low-Ignition Potential Cigarettes, vol. 5, Part 1.
49. Walton K., Walker R., van de Sandt J.J., Castell J.V., Knapp A.G., Kozianowski G., Roberfroid M., and Schilter B. The application of in vitro data in the derivation of the acceptable daily intake of food additives. Food and Chemical Toxicology 37 (1999) 1175-1197